Free Trial

Anteris Technologies Global (AVR) Competitors

Anteris Technologies Global logo
$4.92 -0.20 (-3.91%)
As of 04:00 PM Eastern

AVR vs. EYE, BVS, CBLL, AXGN, EMBC, AVNS, IRMD, SIBN, BFLY, and BBNX

Should you be buying Anteris Technologies Global stock or one of its competitors? The main competitors of Anteris Technologies Global include National Vision (EYE), Bioventus (BVS), CeriBell (CBLL), AxoGen (AXGN), Embecta (EMBC), Avanos Medical (AVNS), Iradimed (IRMD), SI-BONE (SIBN), Butterfly Network (BFLY), and Beta Bionics (BBNX). These companies are all part of the "medical equipment" industry.

Anteris Technologies Global vs.

National Vision (NASDAQ:EYE) and Anteris Technologies Global (NASDAQ:AVR) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, risk, dividends, institutional ownership, media sentiment and profitability.

Anteris Technologies Global has a net margin of 0.00% compared to National Vision's net margin of -0.81%. National Vision's return on equity of 3.52% beat Anteris Technologies Global's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision-0.81% 3.52% 1.39%
Anteris Technologies Global N/A N/A N/A

Anteris Technologies Global has lower revenue, but higher earnings than National Vision.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.82B0.58-$65.90M-$0.36-37.39
Anteris Technologies Global$2.71M65.38N/AN/AN/A

National Vision received 250 more outperform votes than Anteris Technologies Global when rated by MarketBeat users. However, 100.00% of users gave Anteris Technologies Global an outperform vote while only 64.80% of users gave National Vision an outperform vote.

CompanyUnderperformOutperform
National VisionOutperform Votes
254
64.80%
Underperform Votes
138
35.20%
Anteris Technologies GlobalOutperform Votes
4
100.00%
Underperform Votes
No Votes

National Vision presently has a consensus target price of $14.00, indicating a potential upside of 4.01%. Anteris Technologies Global has a consensus target price of $16.50, indicating a potential upside of 235.37%. Given Anteris Technologies Global's stronger consensus rating and higher probable upside, analysts plainly believe Anteris Technologies Global is more favorable than National Vision.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.17
Anteris Technologies Global
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, National Vision had 4 more articles in the media than Anteris Technologies Global. MarketBeat recorded 8 mentions for National Vision and 4 mentions for Anteris Technologies Global. National Vision's average media sentiment score of 0.70 beat Anteris Technologies Global's score of 0.33 indicating that National Vision is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Vision
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Anteris Technologies Global
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

National Vision and Anteris Technologies Global tied by winning 6 of the 12 factors compared between the two stocks.

Remove Ads
Get Anteris Technologies Global News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVR vs. The Competition

MetricAnteris Technologies GlobalSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$177.24M$9.14B$5.68B$8.32B
Dividend YieldN/A1.41%4.55%4.02%
P/E RatioN/A17.6824.5519.25
Price / Sales65.3870.05395.7294.09
Price / CashN/A19.6738.1634.64
Price / BookN/A5.657.064.46
Net IncomeN/A$284.66M$3.19B$247.07M
7 Day Performance-22.15%2.33%1.49%3.05%
1 Month Performance-31.38%-1.93%5.87%-2.85%
1 Year PerformanceN/A-15.84%14.94%4.63%

Anteris Technologies Global Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVR
Anteris Technologies Global
N/A$4.92
-3.9%
$16.50
+235.4%
N/A$177.24M$2.71M0.00138
EYE
National Vision
1.4778 of 5 stars
$11.56
-2.9%
$14.00
+21.1%
-38.5%$910.73M$1.82B-57.8014,000Positive News
BVS
Bioventus
3.4886 of 5 stars
$9.61
-4.6%
$15.00
+56.1%
+78.7%$779.90M$555.06M-15.751,200News Coverage
CBLL
CeriBell
N/A$21.40
-0.7%
$32.60
+52.3%
N/A$767.58M$65.44M0.00N/AGap Up
AXGN
AxoGen
2.2111 of 5 stars
$17.16
-1.7%
$20.75
+20.9%
+146.9%$760.94M$187.34M-53.63450News Coverage
Gap Up
EMBC
Embecta
4.5357 of 5 stars
$13.00
-3.8%
$23.00
+76.9%
+3.6%$755.74M$1.11B13.002,100Positive News
AVNS
Avanos Medical
2.2444 of 5 stars
$14.43
-1.2%
N/A-26.1%$663.82M$687.80M42.443,771Analyst Revision
News Coverage
IRMD
Iradimed
4.8776 of 5 stars
$51.44
-2.6%
$72.00
+40.0%
+22.2%$654.06M$73.24M34.29110
SIBN
SI-BONE
4.236 of 5 stars
$14.71
-0.3%
$24.50
+66.6%
-2.8%$624.48M$167.18M-15.99350Positive News
BFLY
Butterfly Network
0.9855 of 5 stars
$2.56
-5.0%
$3.00
+17.4%
+177.0%$620.67M$82.06M-5.55460
BBNX
Beta Bionics
N/A$14.04
-3.2%
$24.83
+76.9%
N/A$601.74M$53.03M0.00294Earnings Report
News Coverage
Remove Ads

Related Companies and Tools


This page (NASDAQ:AVR) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners